在稳定的严重慢性阻塞性肺病中优化超越三重治疗的管理:随机对照试验中辅助口服多克索菲林的有效性
Bhagiradhi Thimmapuram1, Subramanian Suriyan2, Nagarjun Sakthivel3
1Junior Resident, Department of Respiratory Medicine, SRM Medical College Hospital and Research Centre, Chennai, Tamil Nadu, India, Orcid: https://orcid.org/0009-0008-2136-7879.
The Journal of the Association of Physicians of India
|November 24, 2025
概括
将口服多克索菲林添加到三重吸入器治疗中,在严重的COPD患者中改善了症状并减少了炎症. 虽然螺旋计没有显示任何显著的变化,但多克索菲林耐受性很好,为持久症状提供了潜在的选择.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学 是一个学科.
背景情况:
- 慢性阻塞性肺病 (COPD) 管理通常涉及三重吸入器治疗 (长效β-激动剂,长效肌抗体,吸入性皮质类固醇).
- 尽管最佳的吸入器治疗,但COPD患者的持续症状需要探索辅助治疗.
- 多克索菲林是一种新型的丁衍生物,具有潜在的支气管扩展和抗炎功效,并具有更好的安全性.
研究的目的:
- 为了评估添加口服多克索菲林到稳定的严重COPD标准三重吸入器治疗的疗效和安全性.
- 评估多克索菲林对症状负担,全身炎症和呼吸功能的影响.
主要方法:
- 一项随机对照试验,涉及78名患有稳定严重慢性肺炎的患者.
- 参与者被分配到三重治疗加上口服多克索菲林 (650毫克每天一次) 或单独三重治疗.
- 评估包括COPD评估测试 (CAT) 评分,C反应蛋白 (CRP),螺旋计 (FEV1,FEV1%,FEV1/FVC) 和基线和90天的不良事件.
主要成果:
- 与对照组相比,接受多克索菲林的患者在CAT得分和CRP水平上显著改善.
- 两组之间没有观察到螺旋计参数 (FEV1,预测FEV1%,FEV1/FVC%) 的显著差异.
- 轻微的不良事件,如心,和恶心在多克索菲林组中更频繁,但通常耐受良好.
结论:
- 辅助口服多克索菲林显著减轻症状负担,并减少系统性炎症严重的COPD患者在三重治疗.
- 多克索菲林不提供额外的螺旋计益处,但耐受性很好,使其成为选择性COPD患者具有持续症状的可行选择.
- 这项研究支持多克索菲林作为一种潜在的辅助治疗,用于管理严重的COPD,当单独使用三重吸入器治疗不足时.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
706
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
706
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.0K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.0K
Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K


